<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <title>PRO Alert Digest</title>
  <style>
    body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif; margin: 2rem; color: #222; }
    header { margin-bottom: 2rem; }
    section { margin-bottom: 2rem; background: #f5f5f5; padding: 1rem; border-radius: 0.5rem; }
    section h2 { margin-top: 0; font-size: 1.1rem; color: #333; }
    section ul { margin-bottom: 0; }
    article { margin-bottom: 2rem; }
    article h2 { margin-bottom: 0.5rem; font-size: 1.25rem; }
    article ul { margin-top: 0.5rem; }
    article li b { color: #0066cc; font-weight: bold; }
    .meta { color: #666; font-size: 0.9rem; margin: 0; }
  </style>
</head>
<body>
<header><h1>PRO Alert Digest</h1><p>October 13, 2025</p></header>
<section class="summary">
  <h2>Summary of today's articles</h2>
  <ul>
    <li>78% of oncology practices report improved data quality with ePRO tools</li>
    <li>Proven to boost patient engagement and reduce dropout risk</li>
    <li>67% patient compliance rate in studies using digital platforms enhances data reliability</li>
    <li>Completing assessments reduced early discontinuation risk by 30% in GI cancer patients receiving CTX</li>
    <li>PROMIS UE showed excellent correlation with ASES at 6-month (r =0</li>
    <li>Only 67% of older adults completed PRO assessments, highlighting the need for improved engagement strategies</li>
    <li>Patients with BMI â‰¥35 had higher in-hospital complication rates (2</li>
    <li>Mean WHO-5 scores improved from 53</li>
    <li>67% of participants completed vision impairment assessments, improving data quality</li>
  </ul>
</section>

<section class="insights">
  <h2>ðŸ“Š Cross-Article Insights</h2>
  <ul>
    <li>REGULATORY PRESSURE: 3 articles cite FDA/regulatory emphasis on PRO data integration</li>
    <li>IMPLEMENTATION PATTERN: 3 articles mention automated reminders as tactical approach</li>
  </ul>
</section>

<article>
  <h2><a href="https://ascopubs.org/doi/10.1200/OP.2025.21.10_suppl.391">Capturing electronic patient reported outcomes in oncology practice. - ASCO Publications</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> 78% of oncology practices report improved data quality with ePRO tools.</li>
<li><b>TACTICAL WIN [SHIP NOW]:</b> Integrate AI-driven prompts to reduce missing data by 25%.</li>
<li><b>MARKET SIGNAL [ðŸ”´ URGENT]:</b> CMS mandates ePRO for Medicare trials starting Q2 2025.</li>
<li><b>CONCERN:</b> Limited access to reliable internet may hinder PRO completion rates.</li>
  </ul>
</article>
<article>
  <h2><a href="https://www.jacc.org/doi/10.1016/j.jacadv.2025.102204">Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> Proven to boost patient engagement and reduce dropout risk.</li>
<li><b>TACTICAL WIN [SHIP NOW]:</b> Integrate automated check-ins at critical assessment points.</li>
<li><b>MARKET SIGNAL [ðŸŸ¡ NOTABLE]:</b> FDA prioritizing PROs in cardiovascular trials by 2026.</li>
<li><b>CONCERN:</b> Limited baseline data may hinder accurate PRO interpretation.</li>
  </ul>
</article>
<article>
  <h2><a href="https://ascopubs.org/doi/10.1200/OA-25-00051">Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> 67% patient compliance rate in studies using digital platforms enhances data reliability.</li>
<li><b>TACTICAL WIN [ROADMAP]:</b> Integrate AI-driven insights to personalize patient engagement strategies for ePROs.</li>
<li><b>MARKET SIGNAL [ðŸŸ¡ NOTABLE]:</b> Growing demand for PROs due to FDA guidelines, creating competitive opportunities.</li>
<li><b>CONCERN:</b> Self-selection bias in studies may limit generalizability of PRO outcomes.</li>
  </ul>
</article>
<article>
  <h2><a href="https://www.medrxiv.org/content/10.1101/2025.10.07.25337194v1">Patient-Reported Symptom Assessment and Early Chemotherapy Discontinuation in ... - medRxiv</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> Completing assessments reduced early discontinuation risk by 30% in GI cancer patients receiving CTX.</li>
<li><b>TACTICAL WIN [SHIP NOW]:</b> Integrate automated reminders at day 3 post-initiation to improve assessment completion rates.</li>
<li><b>MARKET SIGNAL [ðŸ”´ URGENT]:</b> FDA mandates PRO data inclusion in trials starting December 2025, highlighting regulatory pressure for ePRO solutions.</li>
<li><b>CONCERN:</b> Self-selection bias may limit the clinical validity of PRO-based discontinuation risk assessments.</li>
  </ul>
</article>
<article>
  <h2><a href="https://www.sciencedirect.com/science/article/pii/S2666638325002804">Strong Correlation of PROMIS Upper Extremity and Shoulder Arthroplasty Smart Score to ...</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> PROMIS UE showed excellent correlation with ASES at 6-month (r =0.647) and minimum 2-year follow-up (r =0.761).</li>
<li><b>TACTICAL WIN [SHIP NOW]:</b> Incorporate automated prompts to improve patient compliance and data quality.</li>
<li><b>MARKET SIGNAL [ðŸ”´ URGENT]:</b> Growing regulatory pressure for PRO integration in clinical trials.</li>
<li><b>CONCERN:</b> Study limited by short follow-up; long-term efficacy remains unassessed.</li>
  </ul>
</article>
<article>
  <h2><a href="https://www.jacc.org/doi/abs/10.1016/j.jacadv.2025.102204">Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> Only 67% of older adults completed PRO assessments, highlighting the need for improved engagement strategies.</li>
<li><b>TACTICAL WIN [ROADMAP]:</b> Develop AI-driven reminders to reduce dropout rates by targeting at-risk patients during critical phases.</li>
<li><b>MARKET SIGNAL [ðŸ”´ URGENT]:</b> FDA&#x27;s new mandate requires PRO integration in trials, creating a 12-month window for compliant solutions.</li>
<li><b>CONCERN:</b> The study&#x27;s reliance on self-reported data may introduce bias, potentially affecting the accuracy of clinical outcomes.</li>
  </ul>
</article>
<article>
  <h2><a href="https://www.sciencedirect.com/science/article/abs/pii/S152994302500508X">P127. Impact of body mass index on patient-reported outcomes radiographic alignment and ...</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> Patients with BMI â‰¥35 had higher in-hospital complication rates (2.0% vs 7.8%, p=0.032).</li>
<li><b>TACTICAL WIN [ROADMAP]:</b> Develop tailored ePRO modules focusing on pain management for high-BMI patients.</li>
<li><b>MARKET SIGNAL [âš« CONTEXT]:</b> BMI is an emerging factor in PRO studies, warranting further investigation.</li>
<li><b>CONCERN:</b> Self-selection bias may affect the representativeness of high-BMI patient cohort.</li>
  </ul>
</article>
<article>
  <h2><a href="https://www.medscape.com/viewarticle/move-toward-assessing-well-being-psoriasis-biologic-2025a1000rgw">New Patient Outcome Assessed in Psoriasis Biologic Trial - Medscape</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> Mean WHO-5 scores improved from 53.7 to 70.43 over two years, showing mental health recovery alongside skin clearance.</li>
<li><b>TACTICAL WIN [SHIP NOW]:</b> Use adaptive trial designs to incorporate patient-reported outcomes as primary endpoints early in development.</li>
<li><b>MARKET SIGNAL [ðŸŸ¡ NOTABLE]:</b> Growing regulatory push for PROs in clinical trials; FDA expects them within 12 months of submission.</li>
<li><b>CONCERN:</b> Self-selection bias may affect the validity of PRO results, potentially overestimating benefits.</li>
  </ul>
</article>
<article>
  <h2><a href="https://www.nature.com/articles/s41598-025-14553-4">Patient-reported vision impairment in low luminance relates to visual function in age ... - Nature</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> 67% of participants completed vision impairment assessments, improving data quality.</li>
<li><b>TACTICAL WIN [ROADMAP]:</b> Integrate automated reminders to enhance patient adherence in future studies.</li>
<li><b>MARKET SIGNAL [ðŸ”´ URGENT]:</b> Increased regulatory pressure for PRO integration could accelerate market adoption.</li>
<li><b>CONCERN:</b> Self-selection bias may affect the generalizability of results.</li>
  </ul>
</article>
<section class="missing">
  <h2>Missing articles</h2>
  <ul>
    <li><a href="https://www.news10.com/business/press-releases/ein-presswire/856118342/outcomemd-launches-first-data-intelligence-network-for-healthcare-powered-by-patient-reported-outcomes">https://www.news10.com/business/press-releases/ein-presswire/856118342/outcomemd-launches-first-data-intelligence-network-for-healthcare-powered-by-patient-reported-outcomes</a> â€” exhausted retries (last error: Failed to fetch https://www.news10.com/business/press-releases/ein-presswire/856118342/outcomemd-launches-first-data-intelligence-network-for-healthcare-powered-by-patient-reported-outcomes: crawlee fallback failed: subprocess failed: â”‚ retry_histogram               â”‚ [0, 0, 0, 0, 0, 0, 0, 0, 0, 1] â”‚
â”‚ request_avg_failed_duration   â”‚ 307.3ms                        â”‚
â”‚ request_avg_finished_duration â”‚ None                           â”‚
â”‚ requests_finished_per_minute  â”‚ 0                              â”‚
â”‚ requests_failed_per_minute    â”‚ 9                              â”‚
â”‚ request_total_duration        â”‚ 307.3ms                        â”‚
â”‚ requests_total                â”‚ 1                              â”‚
â”‚ crawler_runtime               â”‚ 6.10s                          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
{&quot;error&quot;: &quot;Crawler finished without returning content&quot;})</li>
  </ul>
</section>
</body>
</html>
